STRATA Skin Sciences, Inc. Reschedules Fiscal 2017 Financial Results and Corporate Update Call to Monday, April 2 at 8:30 am Eastern Time

HORSHAM, Pa., March 29, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release fiscal 2017 financial results on Monday, April 2, before the market opens. STRATA Skin Sciences’ President and Chief Executive Officer, Frank J. McCaney, will host a conference call at 8:30 am Eastern Time to review the Company’s progress.

Conference Call Details:
Date:Monday, April 2
Time:8:30 am Eastern Time
Toll Free:888-394-8218
International:323-794-2149
Passcode:6380302
Webcast:www.strataskinsciences.com

About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.

Investor Contacts:
Frank McCaney, Chief Executive OfficerBob Yedid, Managing Director
STRATA Skin Sciences, Inc.LifeSci Advisors, LLC
215-619-3200646-597-6989
fmccaney@strataskin.comBob@LifeSciAdvisors.com

Source:STRATA Skin Sciences, Inc.